GxP Compliance Software: Training and Quality Management for Regulated Industries

Paper batch records create the gaps inspectors find.

GxP Quality Management Software: A Single Validated Platform for GMP, GCP, GLP, GDP, and GPvP Quality and Training Records

GxP is not a single regulation. It is an umbrella term for a family of Good Practice quality standards — GMP, GCP, GLP, GDP, and GPvP — each governing a different segment of the pharmaceutical and life sciences value chain. An organisation that manufactures a drug product, runs clinical trials, operates a non-clinical testing laboratory, distributes through a cold-chain network, and monitors post-market safety reports is operating under multiple GxP frameworks simultaneously, each with its own quality system requirements and its own mandatory training obligations.

The question that brings quality professionals to this page is not academic. It is operational: what software system can manage quality records and training records across multiple GxP frameworks, satisfy the 21 CFR Part 11 validation requirement that applies to any computer system used for GxP records, and do it in a single platform rather than a collection of separately validated point solutions? eLeaP is that platform. This page covers the GxP frameworks, what validated GxP quality management software requires, and how eLeaP delivers across all five.

The GxP Umbrella: Five Frameworks, Five Sets of Quality System Requirements

GxP stands for Good (x) Practice, where x identifies the practice domain. Each framework governs a specific regulated activity and imposes specific quality system and training requirements on organisations conducting that activity.

GMP — Good Manufacturing Practice

Good Manufacturing Practice governs the manufacture of pharmaceutical products, biological products, and medical devices. In the United States, GMP is defined by 21 CFR Parts 210, 211 (finished pharmaceuticals), 600 series (biological products), and 820 (medical devices, now the QMSR). In Europe, GMP is defined by EU GMP Parts I and II and a series of technical annexes. GMP quality system requirements include batch production records, deviation management, CAPA, change control, equipment qualification, process validation, and document control. GMP training is required by 21 CFR Part 211.68, which mandates that personnel engaged in drug product manufacturing have the education, training, and experience to perform their assigned functions.

GCP — Good Clinical Practice

Good Clinical Practice governs the conduct of clinical trials involving human subjects. The international standard is ICH E6(R3), adopted by FDA, EMA, and health authorities across major regulated markets. GCP quality system requirements include protocol deviation management, investigator site oversight, informed consent documentation, essential documents management, and audit trails for clinical data. GCP training is required by ICH E6(R3) Section 4.1, which requires that investigators and trial staff be qualified by education, training, and experience to perform their respective tasks, with training records maintained and available for inspection by the sponsor and by regulatory authorities.

GLP — Good Laboratory Practice

Good Laboratory Practice governs non-clinical safety studies conducted to support regulatory submissions. In the United States, GLP is defined by 21 CFR Part 58. Internationally, the OECD GLP principles apply. GLP quality system requirements include study plan and protocol control, raw data integrity, specimen management, equipment calibration and maintenance records, and quality assurance unit independence and oversight. GLP training requirements mandate that all personnel involved in the conduct of a study have the education, training, and experience to perform their assigned functions, with training records available for inspection. The quality assurance unit must verify that personnel are properly trained for their assigned functions.

GDP — Good Distribution Practice

Good Distribution Practice governs the storage and distribution of pharmaceutical products, ensuring that product quality is maintained throughout the supply chain from manufacturer to end user. In Europe, GDP is defined by the EU GDP Guidelines 2013/C 343/01. In the United States, the FDA’s drug supply chain security requirements under the Drug Supply Chain Security Act impose equivalent obligations. GDP quality system requirements include temperature-monitored storage, transportation qualification, distributor qualification, complaint handling for distribution-related quality events, and recall management. GDP training requirements mandate that distribution personnel are trained on the procedures governing the activities they perform, with training records maintained.

GPvP — Good Pharmacovigilance Practice

Good Pharmacovigilance Practice governs the safety monitoring of medicinal products after approval and during clinical development. In Europe, GPvP is defined by EU GVP Modules published by EMA. In the United States, the FDA’s pharmacovigilance system requirements under 21 CFR Parts 312 and 314 apply. GPvP quality system requirements include individual case safety report management, signal detection procedures, periodic safety update report preparation, risk management plan maintenance, and audit of pharmacovigilance system compliance. GPvP training requirements mandate that pharmacovigilance personnel are trained on the procedures governing their safety monitoring functions, with training records available for GPvP audits.

The Validated System Requirement: What It Means and Who Is Responsible for What

Any computer system used to create, modify, maintain, archive, retrieve, or transmit records required by GxP regulations must be validated before it is used for those purposes. This is the fundamental requirement of 21 CFR Part 11 for FDA-regulated activities and EU Annex 11 for European GxP activities. The validation requirement applies to the GxP quality management software itself, not just to the manufacturing systems it monitors. A QMS platform used to manage GMP batch records, GCP protocol deviation records, or GLP study documentation is a GxP-applicable computerised system and must be validated accordingly.

Validation responsibility is shared between the software vendor and the regulated user. The distinction matters: misunderstanding it leads organisations to either over-reliance on vendor documentation and skip required customer validation activities, or to over-invest in validation work that the vendor has already completed. eLeaP provides the following as part of its GxP validation support package.

What eLeaP provides:

What the customer is responsible for:

How eLeaP Delivers GxP Quality Management Software Compliance: Four System Capabilities

GxP quality management software compliance is not a marketing claim. It is a set of specific system capabilities that must be present, configured correctly, and validated. eLeaP delivers each of the following capabilities as native platform architecture, not as optional add-ons or integrations that introduce additional validation complexity.

21 CFR Part 11 Audit Trail

21 CFR Part 11 requires that computerised systems maintain secure, computer-generated, time-stamped audit trails that independently record the date and time of operator entries and actions that create, modify, or delete electronic records. The audit trail must be available for review and copying by the FDA. In eLeaP, the audit trail captures every record creation, modification, and deletion with the operator’s unique identifier, the date and time of the action, and the specific change made. The audit trail is tamper-evident: it cannot be modified or deleted by any user, including system administrators. The audit trail covers all GxP-applicable records in the system — quality records, training records, document revisions, workflow actions, and system configuration changes.

Role-Based Access Controls

21 CFR Part 11 requires that system access be limited to authorised individuals and that the system use operational system checks to enforce permitted sequencing of steps. GxP organisations require access controls that reflect the GxP responsibilities of each role: a GCP clinical data manager should not have write access to GMP manufacturing records, and a GMP production operator should not have access to GCP investigator site records. eLeaP’s role-based access configuration applies access at the record type, workflow stage, and organisational unit level. Access configuration is maintained in the system’s validated configuration, and changes to access assignments are captured in the audit trail. Periodic access review is supported by a system report showing all users, their assigned roles, and their access permissions at the time of the report.

Electronic Signatures with Part 11 Compliance

21 CFR Part 11 requires that electronic signatures be unique to one individual, not reused or reassigned to another individual, and bound to their respective electronic records so that the signatures cannot be excised, copied, or otherwise transferred to falsify a record. eLeaP’s electronic signatures are bound to the specific record being signed through a cryptographic linkage that makes any subsequent modification to the signed record detectable. Each signature requires the signer’s unique identification code and a confirmation password at the time of signing — the two identification components required by Part 11. The signature record captures the signer’s identity, the date and time, and the meaning of the signature as defined in the workflow configuration.

System Change Control Procedures

Maintaining a validated state requires that changes to the GxP quality management software — configuration changes, workflow changes, user role changes, and platform updates from eLeaP — are assessed for impact on the validated state and are implemented through a documented change control process. eLeaP provides advanced notification of platform updates with change assessment documentation that supports the customer’s impact evaluation. The customer’s change control procedure for system changes requires documenting the change, assessing its impact on the validated state, executing any required regression testing, updating the validation documentation, and obtaining quality unit approval before the change is effective in the GxP environment. eLeaP’s system change notification documentation is designed to support each step of the customer’s change control evaluation.

GxP Training Management: The Requirement Across Every Good Practice Framework

Training is a regulatory requirement under every GxP framework, not a best practice. GMP training is required by 21 CFR Part 211.68. GCP training is required by ICH E6(R3) Section 4.1. GLP training is required by 21 CFR Part 58.29. GDP training is required by the EU GDP Guidelines Section 3.2. GPvP training is required by the EU GVP Module I. Each framework requires not only that training occur but that training records be maintained and available for inspection or audit.

The training management challenge in a multi-GxP organisation is that each framework imposes training requirements specific to the activities it governs. A GMP production operator’s training matrix covers GMP SOPs, validated processes, and GMP regulatory qualification. A GCP clinical research associate’s training matrix covers ICH E6(R3), protocol-specific training, and therapeutic area qualifications. A GLP study director’s training matrix covers OECD GLP principles, study plan review procedures, and study conduct qualifications. Maintaining these separate training profiles in a system that is also managing the quality records those procedures govern requires either a single integrated QMS and LMS or a separately validated LMS connected to the QMS through a data interface that introduces additional validation complexity.

eLeaP is the only platform that manages both GxP quality records and GxP training records in a single validated system. The QMS and LMS share the same platform, the same database, the same audit trail, and the same Part 11 compliance architecture. A GxP inspector who wants to see a specific employee’s training records alongside the quality records for the activities that employee performed views both in the same system, from the same query, with the same audit trail coverage. There is no reconciliation between systems, no API dependency, and no separate validation scope for the training system.

When a GxP procedure is revised — whether it is a GMP SOP, a GCP protocol, a GLP study plan procedure, or a GDP distribution procedure — eLeaP automatically identifies every role assigned to that procedure in the training matrix and creates retraining assignments for every person in those roles. The training assignment carries the procedure version number. Completion records link to the specific version. A GxP inspector asking whether personnel were trained on the version of a procedure in effect on a specific date receives a single-query response from the system without manual reconciliation across separate records.

Evaluating GxP Quality Management Software: Five Questions That Establish Fitness for Purpose

GxP quality management software must satisfy the regulatory requirements of each GxP framework the organisation operates under, the 21 CFR Part 11 and EU Annex 11 validated system requirements, and the practical operational requirements of managing quality and training records across multiple practice domains. The questions below test fitness for purpose across all three dimensions.

eLeaP’s answers to all five questions are yes, demonstrable in a scoped GxP platform walkthrough configured for the buyer’s primary practice domain. The demo covers the quality record and training record architecture for GMP, GCP, or GLP as applicable, the audit trail and electronic signature demonstration, and the validation support package overview. Request a scoped GxP demo at eleapsoftware.com.

Related resources: